PointState Capital’s Omnicell OMCL Stock Holding History

PointState Capital’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-22,000	Closed	-$2.64M	–	156
2020 Q4	$2.64M	Buy	+22,000	New	+$2.16M	0.05%	107

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

PointState Capital's OMCL Position: Q1 2021 in Review

PointState Capital sold out of Omnicell (OMCL) in Q1 2021, closing a stake of 22,000 shares — an estimated $2.64M sold.

PointState Capital first reported a position in OMCL in Q4 2020 and held it in 1 quarter. The position peaked at $2.64M in Q4 2020. 380 funds tracked by Wall St. Rank hold OMCL as of Q1 2021.

PointState Capital reported no remaining Omnicell position as of Q1 2021 after selling out during the quarter.
PointState Capital sold 22,000 Omnicell shares in Q1 2021, an estimated $2.64M.
PointState Capital first reported a position in Omnicell in Q4 2020 and held it in 1 quarter.
PointState Capital's Omnicell position peaked at $2.64M in Q4 2020.
380 funds tracked by Wall St. Rank held Omnicell as of Q1 2021.

Based on PointState Capital's 13F filing for Q1 2021, filed 14 May 2021.